PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18819794-0	2008	Itk kinase inhibitors: initial efforts to improve the metabolical stability and the cell activity of the benzimidazole lead.	benzimidazole	105-118	IL2 inducible T cell kinase	Homo sapiens	0-3	
18819794-1	2008	Previously, we reported a series of novel benzimidazole based Itk inhibitors that exhibited excellent enzymatic potency and selectivity but low microsomal stability.	benzimidazole	42-55	IL2 inducible T cell kinase	Homo sapiens	62-65	
18819799-1	2008	A series of novel potent benzimidazole based inhibitors of interleukin-2 T-cell kinase (Itk) were prepared.	benzimidazole	25-38	IL2 inducible T cell kinase	Homo sapiens	59-86	
18819799-1	2008	A series of novel potent benzimidazole based inhibitors of interleukin-2 T-cell kinase (Itk) were prepared.	benzimidazole	25-38	IL2 inducible T cell kinase	Homo sapiens	88-91	
17499505-0	2007	Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitors.	benzimidazole	23-36	IL2 inducible T cell kinase	Homo sapiens	51-54